PulseExploreJournal ClubDebatesTrendingResearchersJournals
Instagram
HomeExploreJournal ClubTrending
Synapse
⌘+K
Synapse
May 28, 2026The Journal of Experimental Medicine1 citations

Targeting UBE2F induces a resilience program enhancing CD8 T cell immunity

View Full Paper
XMXiaonan MaHGHenan GuoYJYuting Jia

Key Points

  • The study aims to explore how targeting UBE2F can enhance the longevity and functional capacity of CD8 T cells.
  • Ablation of UBE2F in CD8 T cells to induce resilience.
  • Mechanistic analysis of the UBE2F–CUL5–JUNB–IL-2Rβ axis.
  • Assessment of viral and tumor control in response to UBE2F deficiency.
  • UBE2F ablation leads to improved CD8 T cell self-renewal and survival.
  • IL-2Rβ expression upregulation enhances CD8 T cell sensitivity to IL-15.
  • Enhanced control of viral and tumor activity observed without disrupting differentiation.

Abstract

Memory CD8 T cells (TMEM) and exhausted CD8 T cells (TEX) are essential for host defense against infection and cancer, yet their therapeutic potential is often limited by insufficient persistence and sustained functional capacity. Strategies to enhance the longevity of both populations remain scarce. Here, we demonstrate that ablation of UBE2F, a neddylation E2 enzyme, induces a resilience program in CD8 T cells that operates across both TMEM and TEX compartments, resulting in improved viral and tumor control. This resilience state is characterized by enhanced self-renewal and survival without perturbing the conventional CD8 T cell differentiation trajectories. Mechanistically, UBE2F deficiency inhibited neddylation of CUL5, leading to accumulation of JUNB and upregulation of IL-2Rβ. The increased IL-2Rβ expression hypersensitizes CD8 T cells to physiological IL-15, thereby conferring the resilience features. Together, these findings identify the UBE2F–CUL5–JUNB–IL-2Rβ axis as a conserved posttranslational mechanism regulating CD8 T cell longevity across memory and exhausted states, providing a novel strategy for enhancing antiviral and antitumor immunity.

Ask AI
Helpful
Bookmark
Share
View Full Paper

Cite This Study

Ma et al. (2026) studied this question.

synapsesocial.com/papers/6a17dc233fad632b0f9d8d3dhttps://doi.org/10.1084/jem.20252687
Ask AI
Helpful
Bookmark
Share
View Full Paper